Vstm stocktwits.

VSTM Verastem, Inc. Stock Price & Overview $7.75 0.35 ( +4.73%) 4:00 PM 10/05/23 NASDAQ | $USD | Post-Market: $7.99 +0.24 (+3.10%) 4:14 PM Summary Ratings Financials Earnings Dividends Valuation...VSTM on Twitter. Verastem, Inc., a biopharmaceutical company, focuses on discovering and developing proprietary small molecule drugs targeting cancer stem cells (CSCs) with companion diagnostics. Its programs target the Focal Adhesion Kinase (FAK) and the PI3K/mTOR signaling pathways. The company's lead FAK inhibitor, VS-6063, is in Phase I/Ib ...View the latest Verastem Inc. (VSTM) stock price, news, historical charts, analyst ratings and financial information from WSJ.Get the latest Verastem, Inc. (VSTM) stock news and headlines to help you in your trading and investing decisions.

VSTM Stock Predictions - will VSTM go up or down? - free VSTM analysis to find out whether to buy or sell VSTM. Secret Penny Stocks Guide +128.38%: Penny Stocks: OTC Penny Stocks: ... Check out VSTM StockTwits on Stocktwits or Twitter to see what others have to say about the stock. Learn how to trade penny stocks. Complete Penny Stocks …Verastem gets $3.8M award for VS-6766/defactinib combo trial to treat pancreatic cancer. SA NewsWed, May 18, 2022.Track Stealth BioTherapeutics Corp (MITO) Stock Price, Quote, latest community messages, chart, news and other stock related information. Share your ideas and get valuable insights from the community of like minded traders and investors

All groups and messages ... ...Verastem Oncology (NASDAQ:VSTM) COO and President Dan Paterson has been promoted to President and Chief Executive Officer role, effective August 1, 2023.Brian Stuglik will retire from the CEO role ...

By Karl Utermohlen, InvestorPlace Writer Dec 15, 2017. DDR (DDR) to spin off 50 properties, Hess (HES) to dethrone John Hess as CEO and Verastem (VSTM) announces $25 million common share offering.Find the latest Verastem, Inc. (VSTM) stock quote, history, news and other vital information to help you with your stock trading and investing.Jul 31, 2023 · Verastem Inc (VSTM) stock is higher by 4.56% while the S&P 500 is down -0.05% as of 1:24 PM on Monday, Jul 31. VSTM is up $0.47 from the previous closing price of $10.30 on volume of 179,569 shares. Over the past year the S&P 500 is higher by 11.20% while VSTM is down -16.90%. VSTM lost -$4.44 per share in the over the last 12 months. Track Rolls-Royce Holding PLC (ADR) (RYCEY) Stock Price, Quote, latest community messages, chart, news and other stock related information. Share your ideas and get valuable insights from the community of like minded traders and investorsTrack Invesco QQQ Trust Series 1 (QQQ) Stock Price, Quote, latest community messages, chart, news and other stock related information. Share your ideas and get valuable insights from the community of like minded traders and investors

Track SPDR S&P 500 ETF (SPY) Stock Price, Quote, latest community messages, chart, news and other stock related information. Share your ideas and get valuable insights from the community of like minded traders and investors

Indicators. Parameters. Position. - None - Accum/Distribution Line Aroon Aroon Oscillator ADX Line ADX Line (w/+DI and -DI) Avg True Range (ATR) Bollinger Band Width Bollinger %B Commodity Channel Index (CCI) Correlation Chaikin Money Flow (CMF) Chaikin Oscillator Coppock Curve Chande Trend Meter Date/Time Axis Detrended Price (DPO) Dividends ...

A high-level overview of Verastem, Inc. (VSTM) stock. Stay up to date on the latest stock price, chart, news, analysis, fundamentals, trading and investment tools.Verastem, Inc. is a late-stage development biopharmaceutical company. The Company’s pipeline is focused on anticancer agents that inhibit critical signaling pathways in cancer that promote cancer cell survival and tumor growth, particularly rapidly accelerated fibrosarcoma (RAF)/mitogen-activated protein kinase kinase (MEK) inhibition ...Track Microvast Holdings Inc (MVST) Stock Price, Quote, latest community messages, chart, news and other stock related information. Share your ideas and get valuable insights from the community of like minded traders and investorsFinancial Overview. VSTM ended Q2 2023 with $183 million in cash and equivalents, with total current assets reaching $190 million. Their operating losses for the quarter reached $20.2 million ...VSTM Performance. The chart shows the growth of $10,000 invested in Verastem, Inc. in Jan 2012 and compares it to the S&P 500 index or another benchmark. It would be worth nearly $397 for a total return of roughly -96.03%. All prices are adjusted for splits and dividends. ...The predictions for the future VSTM stock price range from a low of $5.00 to a high of $5.00, highlighting the ... Monitoring bullish and bearish sentiments towards Verastem on Twitter and Stocktwits could help to forecast an upward or downward trend in Verastem stock price. 8:00 PM (UTC) Date:10 October, 2023. 0 ...Verastem (VSTM) stock is jumping after the company reported a narrower-than-expected loss for the 2015 fourth quarter. VSTM. OPINION. Mar 2, 2016 6:57 AM EST.

You can follow them on Twitter, Youtube and/or on Stocktwits (a knock off twitter, but just for stocks). ... Ticker: VSTM. Inflection points / Entry Examples that ...Trading at low valuations, with strong upside potential from company-specific catalysts, these are the 7 best penny stocks to buy now. Advantage Solutions ( ADV ): ADV stock trades at a super-low ...BOSTON, January 24, 2023--Verastem Oncology (Nasdaq: VSTM), a biopharmaceutical company committed to advancing new medicines for patients with cancer, today announces positive interim data from ...Total Valuation. Verastem has a market cap or net worth of $249.98 million. The enterprise value is $105.61 million. Market Cap. 249.98M. Enterprise Value. 105.61M.IDEX | Complete Ideanomics Inc. stock news by MarketWatch. View real-time stock prices and stock quotes for a full financial overview.

Find the latest Aemetis, Inc. (AMTX) stock quote, history, news and other vital information to help you with your stock trading and investing.

Verastem Presents Avutometinib and Defactinib Combination Program Updates at the 5th Annual RAS-Targeted Drug Development Summit. BOSTON, September 28, 2023--Verastem Oncology, (Nasdaq: VSTM), a biopharmaceutical company committed to advancing new medicines for patients with cancer, today announced the presentation of scientific background and clinical trial updates on the avutometinib and ...Track Kaixin Auto Holdings (KXIN) Stock Price, Quote, latest community messages, chart, news and other stock related information. Share your ideas and get valuable insights from the community of like minded traders and investors4168d1ba90ad3a47f345f327c055805a._1EofkoNkHtnmsJ0rpkSjU-FgIDsXqTOGQxzqbqyuUI.zD13TH9OyRks3psD9_5czyfax7beEJKpVXVByv757y2eBUcZGXn-Pyb-jw Advanced searchVSTM, $VSTM, Verastem Inc stock technical analysis with charts, breakout and price targets, support and resistance levels, and more trend analysis indicatorsVerastem Presents Avutometinib and Defactinib Combination Program Updates at the 5th Annual RAS-Targeted Drug Development Summit. BOSTON, September 28, 2023--Verastem Oncology, (Nasdaq: VSTM), a biopharmaceutical company committed to advancing new medicines for patients with cancer, today announced the presentation of scientific background and clinical trial updates on the avutometinib and ...BOSTON, May 31, 2023--Verastem Oncology, (Nasdaq: VSTM), a biopharmaceutical company committed to advancing new medicines for patients with cancer, today announced that it will effect a 1-for-12 ...VSTM Performance. The chart shows the growth of $10,000 invested in Verastem, Inc. in Jan 2012 and compares it to the S&P 500 index or another benchmark. It would be worth nearly $397 for a total return of roughly -96.03%. All prices are adjusted for splits and dividends. ...vstm is up 64% since the begininning of the year. vstm is down -15% below 20 day sma. vstm is up 6% above 200 day sma. financials. profitable: no eps: $-1.37. earnings momentum: no 0.63% decrease in qtrly earnings. p/e ratio is: n/a income to debt ratio: 0.00. revenue is: n/a debt is: 50k cash is: 184m.Track Apple Inc. (AAPL) Stock Price, Quote, latest community messages, chart, news and other stock related information. Share your ideas and get valuable insights from the community of like minded traders and investors

VSTM Verastem, Inc. Stock Price & Overview $7.75 0.35 ( +4.73%) 4:00 PM 10/05/23 NASDAQ | $USD | Post-Market: $7.99 +0.24 (+3.10%) 4:14 PM Summary Ratings Financials Earnings Dividends Valuation...

Find the latest Earnings Report Date for Verastem, Inc. Common Stock (VSTM) at Nasdaq.com.

Verastem, Inc. (VSTM) NasdaqCM - NasdaqCM Real Time Price. Currency in USD Follow 2W 10W 9M 8.06 +0.46 (+6.05%) At close: 04:00PM EDTTrack Occidental Petroleum Corp. (OXY) Stock Price, Quote, latest community messages, chart, news and other stock related information. Share your ideas and get valuable insights from the community of like minded traders and investorsTrack Kaixin Auto Holdings (KXIN) Stock Price, Quote, latest community messages, chart, news and other stock related information. Share your ideas and get valuable insights from the community of like minded traders and investorsVSTM, Jan. 11, 2018 / $3.02, Sept. 4, 2018 / $10.07, 233%. PreviousNext. Search ... StockTwits · StockTwits. © 2023 The Growth Portfolio Blog | Powered by ...Find the latest Verastem, Inc. (VSTM) stock quote, history, news and other vital information to help you with your stock trading and investing.Investors may trade in the Pre-Market (4:00-9:30 a.m. ET) and the After Hours Market (4:00-8:00 p.m. ET). Participation from Market Makers and ECNs is strictly voluntary and as a result, these ...PayPal Holdings, Inc. Common Stock. $68.10 +1.37 2.05%. Verastem, Inc. Common Stock (VSTM) After-Hours Stock Quotes - Nasdaq offers after-hours quotes and extended trading activity data for US and ...The average price recommended by analysts for Verastem Inc. (VSTM) i. Moreover, the 36-month beta value for VSTM is 0.70. Analysts have varying opinions on the stock, with 7 analysts rating it as a "buy," 0 as "overweight," 0 as "hold," and 0 as "sell." The average price recommended by analysts for Verastem Inc. (VSTM) i395.72%. Free cash flow. Amount of cash a business has after it has met its financial obligations such as debt and outstanding payments. -13.13M. -104.56%. Get the latest Verastem Inc (VSTM) real ...

The 52 rating InvestorsObserver gives to Verastem Inc stock puts it near the top of the Biotechnology industry. In addition to scoring higher than 78 percent of stocks in the Biotechnology industry, VSTM's 52 overall rating means the stock scores better than 52 percent of all stocks.2 brokers have issued 12 month price objectives for Akebia Therapeutics' stock. Their AKBA share price forecasts range from $3.75 to $3.75. On average, they anticipate the company's share price to reach $3.75 in the next twelve months. This suggests a possible upside of 250.5% from the stock's current price. View analysts price targets for AKBA ...Barchart allows you to view options by Expiration Date (select the expiration month/year using the drop-down menu at the top of the page). Weekly expiration dates are labeled with a (w) in the expiration date list. Options information is delayed a minimum of 15 minutes, and is updated at least once every 15-minutes through-out the day.Instagram:https://instagram. my resman logindynasty process calculatoroutdoor swap meet fontanadrivehub new smyrna beach Read about Verastem Inc (VSTM:XNAS) stock and today's latest news and financial updates.All groups and messages ... ... bankmobile vibe activate cardaustin in gas prices Verastem Oncology Reports Second Quarter 2023 Financial Results and Highlights Recent Company Progress. BOSTON, August 08, 2023--Verastem Oncology (Nasdaq: VSTM), a biopharmaceutical company committed to advancing new medicines for patients with cancer, today reported financial results for the second quarter ending June 30, 2023 and highlighted recent progress.This combo of drugs is a monster. I see 5-15.00 by Jan 2025. In addition to the progress with avutometinib + defactinib in LGSOC ONCT is moving two KRAS-G12C projects forward: avutometinib + sotorasib and avutometinib + adagrasib in KRAS- (G12C) NSCLC. Preclinical data suggests that we should see synergy with these combinations. wawasee skyward VSTM Verastem, Inc. Stock Price & Overview $7.75 0.35 ( +4.73%) 4:00 PM 10/05/23 NASDAQ | $USD | Post-Market: $7.99 +0.24 (+3.10%) 4:14 PM Summary Ratings Financials Earnings Dividends Valuation...A look at the shareholders of Verastem, Inc. (NASDAQ:VSTM) can tell us which group is most powerful.Institutions often own shares in more established companies, while it's not unusual to see ...Verastem In-Licenses KRAS-Focused Drug From Chugai, Stock Up. by Zacks Equity Research Published on January 09,2020. Verastem (VSTM) enters into an agreement with Chugai Pharmaceutical to gain ...